Search

everythinglearnresearchcommunity

for

Search:↓

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Enhancing immune response can improve cancer treatment effectiveness.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Calancardin B may help reduce inflammation in immune cells.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Mogamulizumab can cause hair loss and skin rashes.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

Blocking certain proteins on immune cells may help treat alopecia areata.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Blocking LFA-1 prevents hair loss in mice.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.